Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Profiles of circulating exosomal miRNA in SAPHO patients by high-throughput sequencing

View through CrossRef
Abstract Background: Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare disease characterized by autoinflammatory lesions on bones and skin. Diversified manifestation and inadequate understanding of etiology have limited its diagnosis and treatment. SAPHO syndrome is also classified as primary inflammatory osteitis. The osteoarticular involvement is generally insidious in onset of this disease and associated biomarkers may be of significance for diagnosis, treatment, as well as clarifying the pathogenesis of SAPHO. In this study, we profiled the exosomal miRNA expression in peripheral blood of SAPHO patients to identify key miRNAs associated with this disease and try to find new molecule as potential biomarkers for SAPHO syndrome. Methods: We recruited 6 SAPHO patients and 3 healthy volunteers. The expression profile of miRNAs in circulating exosome was analyzed by next generation sequencing. Linear discriminant analysis effect size analysis and Wilcoxon rank-sum test were used to screen the biomarker based on the differential miRNAs, and the receiver operating characteristic curve was constructed to assess the diagnostic value. We performed Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses to predict their potential functions and related pathways according to the target genes of the differential miRNAs. Results: In total 45 differentially expressed miRNAs in SAPHO patients were identified, among which 22 were upregulated and 23 were downregulated. MiR-144-3p was the most significantly upregulated miRNA. Meanwhile, miR-30d-3p, miR-627-3p, miR-556-5p, miR-18a-5p, miR-2355-3p, miR-24-1-5p, miR-6734-5p, miR-548d-5p, miR-548o-3p, miR-185-3p were distinctly expressed in SAPHO patients and undetectable in healthy volunteers. We identified 4 differential miRNAs (hsa-miR-150-5p, hsa-miR-144-3p, hsa-miR-142-5p and hsa-miR-30d-3) as biomarkers for SAPHO syndrome and the area under the receiver operating characteristic curve was 1. The differential KEGG pathways enriched in immune system and endocrine system, as well as the infectious disease and cancers; while most significantly indicated molecular function in GO function were protein binding and catalytic activity. Conclusion: The exosomal miRNA profile in SAPHO syndrome was significantly changed and could be treated as biomarker to assist the diagnose, while their parts in pathology needed further exploration in the future.
Title: Profiles of circulating exosomal miRNA in SAPHO patients by high-throughput sequencing
Description:
Abstract Background: Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare disease characterized by autoinflammatory lesions on bones and skin.
Diversified manifestation and inadequate understanding of etiology have limited its diagnosis and treatment.
SAPHO syndrome is also classified as primary inflammatory osteitis.
The osteoarticular involvement is generally insidious in onset of this disease and associated biomarkers may be of significance for diagnosis, treatment, as well as clarifying the pathogenesis of SAPHO.
In this study, we profiled the exosomal miRNA expression in peripheral blood of SAPHO patients to identify key miRNAs associated with this disease and try to find new molecule as potential biomarkers for SAPHO syndrome.
Methods: We recruited 6 SAPHO patients and 3 healthy volunteers.
The expression profile of miRNAs in circulating exosome was analyzed by next generation sequencing.
Linear discriminant analysis effect size analysis and Wilcoxon rank-sum test were used to screen the biomarker based on the differential miRNAs, and the receiver operating characteristic curve was constructed to assess the diagnostic value.
We performed Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses to predict their potential functions and related pathways according to the target genes of the differential miRNAs.
Results: In total 45 differentially expressed miRNAs in SAPHO patients were identified, among which 22 were upregulated and 23 were downregulated.
MiR-144-3p was the most significantly upregulated miRNA.
Meanwhile, miR-30d-3p, miR-627-3p, miR-556-5p, miR-18a-5p, miR-2355-3p, miR-24-1-5p, miR-6734-5p, miR-548d-5p, miR-548o-3p, miR-185-3p were distinctly expressed in SAPHO patients and undetectable in healthy volunteers.
We identified 4 differential miRNAs (hsa-miR-150-5p, hsa-miR-144-3p, hsa-miR-142-5p and hsa-miR-30d-3) as biomarkers for SAPHO syndrome and the area under the receiver operating characteristic curve was 1.
The differential KEGG pathways enriched in immune system and endocrine system, as well as the infectious disease and cancers; while most significantly indicated molecular function in GO function were protein binding and catalytic activity.
Conclusion: The exosomal miRNA profile in SAPHO syndrome was significantly changed and could be treated as biomarker to assist the diagnose, while their parts in pathology needed further exploration in the future.

Related Results

Microrna Regulation of Nodule Zone-Specific Gene Expression In Soybean
Microrna Regulation of Nodule Zone-Specific Gene Expression In Soybean
Nitrogen is a paramount important essential element for all living organisms. It has been found to bea crucial structural component of proteins, nucleic acids, enzymes and other ce...
Preanalytical considerations for clinical assays of circulating human miRNA-451a, miRNA-423-5p and miRNA-199a-3p for diagnostic purposes
Preanalytical considerations for clinical assays of circulating human miRNA-451a, miRNA-423-5p and miRNA-199a-3p for diagnostic purposes
Circulating miRNA has recently emerged as important biomolecules with potential clinical values as diagnostic markers for several diseases. However, to be used as such, it is criti...
Transforming growth factor-beta and microRNA-21, microRNA-29b, microRNA-92, and microRNA-129 in systemic sclerosis patients
Transforming growth factor-beta and microRNA-21, microRNA-29b, microRNA-92, and microRNA-129 in systemic sclerosis patients
Background Systemic sclerosis is characterized by extracellular matrix overproduction by activated fibroblasts. It was reported that microRNAs (miRNAs) participate in t...
Lentivirus-mediated long-term overexpression of specific microRNA for complementary miRNA pairs in mammalian cells
Lentivirus-mediated long-term overexpression of specific microRNA for complementary miRNA pairs in mammalian cells
Abstract The establishment of a method that would overexpress or suppress of specific microRNA activity is essential for the functional analysis of these molecules ...
Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients
Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients
BACKGROUND: Osimertinib is an epidermal growth factor receptor-tyrosine kinase inhibitor that specifically targets the T790M mutation in cancer.Unfortunately, most non-small cell l...
Circulating Exosomal miRNA Signature in Pregnancies with Gestational Diabetes Mellitus across Gestation
Circulating Exosomal miRNA Signature in Pregnancies with Gestational Diabetes Mellitus across Gestation
Exosomes are small nanovesicles that carry bioactive molecules (e.g., miRNAs) which can be delivered to other cells and modify their phenotype. Recently, we have established that t...

Back to Top